Carmustine Clinical Trials
5 recruitingDrug
Phase 24Phase 12
Showing 1–5 of 5 trials
Recruiting
Phase 1
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)
Pediatric Solid TumorPediatric Brain Tumor
Washington University School of Medicine20 enrolled1 locationNCT05521984
Recruiting
Phase 2
CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
Diffuse Large B Cell Lymphoma
Washington University School of Medicine36 enrolled1 locationNCT06687772
Recruiting
Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
Recurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma
City of Hope Medical Center33 enrolled1 locationNCT04871607
Recruiting
Phase 2
MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma
Classic Hodgkin LymphomaAutologous Stem Cell Transplant
Masonic Cancer Center, University of Minnesota28 enrolled1 locationNCT06377540
Recruiting
Phase 1Phase 2
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
Glioblastoma Multiforme
VBI Vaccines Inc.98 enrolled12 locationsNCT03382977